FAS and metabolic dysfunction-associated steatotic liver disease: It is believed that miR-130-3p effects on (human fatty acid synthase) FAS expression may be indirectly mediated by reducing PPARs expression since PPARs might control FAS expression [208], thus, playing a role in NAFLD.